ALKS

45.9200.56%
BC

Blair C. Jackson

President, CEO & Director

Mr. Blair C. Jackson is CEO & Director of Alkermes plc from August 1, 2026 and serves as its President. Mr. Jackson is Director of Synchronicity Pharma, Inc. (formerly known as Reset Therapeutics, Inc.) since May 11, 2016. Mr. Jackson served as Executive Vice President and Chief Operating Officer at Alkermes plc since January 2021 until August 1, 2026, Chief Risk Officer until August 1, 2026 and Interim Principal Financial Officer since February 1, 2024 until September 15, 2025. Mr. Jackson served as Senior Vice President of Corporate Planning at Alkermes plc since August 2018 until January 2021 and Senior Vice President of Business Development till August 2018. Mr. Jackson served as Vice President of Business Development and Vice President of Business Development & Program Leadership at Alkermes plc. Mr. Jackson joined Alkermes in 1999 and served in various roles in both a scientific and corporate capacity. Mr. Jackson served as a Director of Civitas Therapeutics, Inc. since December 2010. Mr. Jackson earned a bachelor’s degree in Biochemistry from the University of Calgary in Alberta, Canada, a bachelor’s degree in Chemical Engineering and a Master of Business Administration from the University of Alberta and a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology.

Positions